References
- Kuo HC. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor over-activity refractory to anticholinergic agents. Urology 2004;63:868–72.
- Sahai A, Khan MS, Le Gall N, Dasgupta P. Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder. Urology 2008;71:455–9.
- Ghalayini IF, Al-Ghazo MA. Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor over-activity: urodynamic outcome and patient satisfaction. Neurourol Urodyn 2007;26:531–6.
- Sahai A, Dowson C, Khan MS, Dasgupta P. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor over-activity: results from a randomized double-blind placebo-controlled trial. BJU Int 2009;103:1509–15.
- Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol.
- Wahl EF, Lahdes-Vasama TT, Churchill BM. Enhanced objective quantitative cystometric analysis of compliance and contractility. BJU Int 2004;94:1105–11.
- Hjälmås K. Urodynamics in normal infants and children. Scand J Urol Nephrol 1988;Suppl 112:20–7.
- Houle AM, Gilmour RF, Churchill BM, Gaumond M, Bissonnette B. What volume can a child normally store in the bladder at a safe pressure? J Urol.
- Starfield B. Functional bladder capacity in enuretic and nonenuretic children. Pediatrics 1967;70:777–81.
- Berger RM, Maizels M, Moran GC, Conway JJ, Firlit CF. Bladder capacity (ounces) equals age (years) plus 2 predict normal bladder capacity and aids in diagnosis of abnormal voiding patterns. J Urol 1983;129:347–9.
- Fairhurst JJ, Rubin CME, Hyde I, Freeman NV, Williams JD. Bladder capacity in infants. J Pediatr Surg 1991;26:55–7.
- Nevéus T, von Gontard A, Hoebeke P, Hjälmås K, Bauer S, Bower W, The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol 2006;176:314–24.
- Flynn MK, Amundsen CL, Perevich M, Liu F, Webster GD. Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol 2009;181:2608–15.
- Khan S, Kessler TM, Apostolidis A, Kalsi V, Panicker J, Roosen A, What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type A injection. J Urol 2009;181:1773–8